Curaleaf Holdings, Inc.

General ticker "CURLF" information:

  • Sector: Health Care
  • Industry: Drug Manufacturers - Specialty & Generic
  • Capitalization: $1.2B (TTM average)

Curaleaf Holdings, Inc. follows the US Stock Market performance with the rate: 45.4%.

Estimated limits based on current volatility of 4.6%: low 2.22$, high 2.43$

Factors to consider:

  • Earnings for 9 months up through Q3 are below our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2024-12-31 to 2026-12-31

  • 2024-12-31 to 2025-12-31 estimated range: [1.08$, 2.71$]
  • 2025-12-31 to 2026-12-31 estimated range: [0.97$, 2.36$]

Financial Metrics affecting the CURLF estimates:

  • Positive: with PPE of -8.4 at the end of fiscal year the price was neutral
  • Positive: Operating cash flow per share per price, % of 13.76 > 12.99
  • Positive: -5.04 < Operating profit margin, % of 1.50
  • Positive: 19.41 < Shareholder equity ratio, % of 29.20 <= 42.77
  • Positive: Industry inventory ratio change (median), % of -1.58 <= -0.18
  • Positive: -14.20 < Investing cash flow per share per price, % of -7.94

Similar symbols

Short-term CURLF quotes

Long-term CURLF plot with estimates

Financial data

YTD 2023-12-31 2024-12-31
Operating Revenue $1,371.33MM $1,278.33MM
Operating Expenses $1,327.66MM $1,259.10MM
Operating Income $43.67MM $19.23MM
Non-Operating Income $-170.32MM $-131.21MM
Interest Expense $100.38MM $100.62MM
Income(Loss) $-126.65MM $-111.98MM
Taxes $116.69MM $93.86MM
Profit(Loss)* $-286.35MM $-226.73MM
Stockholders Equity $1,045.27MM $860.70MM
Inventory $214.81MM $220.52MM
Assets $3,080.73MM $2,947.78MM
Operating Cash Flow $76.64MM $154.76MM
Capital expenditure $66.65MM $88.68MM
Investing Cash Flow $-75.89MM $-89.32MM
Financing Cash Flow $-72.49MM $-51.63MM
Earnings Per Share** $-0.40 $-0.31

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.